周四,标准普尔/澳交所200指数微跌0.1%,收于8831.40点,投资者在国内和全球降息押注增加的推动下,在两个创纪录的交易日后锁定利润。投资者预计,8月12日澳大利亚储备银行降息25个基点的可能性超过92%,美联储9月降息的预期也在增加。与此同时,在美国总统特朗普最近宣布对药品征收高额关税,并在最新更新中对半导体进口征收100%的税后,市场变得谨慎。在数据方面,澳大利亚的贸易顺差在2025年6月跃升至53.7亿澳元,为3月以来的最高水平,这得益于出口增长6.0%,达到443.2亿澳元的16个月高点。在企业新闻中,金融和医疗保健股下跌,而ASX有限公司在表示与监管调查有关的成本上升后下跌8.6%。现在的焦点转移到下周的收益上,CBA、西太平洋银行和澳新银行等主要银行将公布财报。
The S&P/ASX 200 edged 0.1% lower to finish at 8,831.40 on Thursday, as investors locked in profits after two record-high sessions driven by rising bets on domestic and global rate cuts. Investors are pricing in over 92% odds of a quarter-point RBA rate cut on August 12, with expectations also building for a US Fed cut in September. Meanwhile, markets turned cautious after US President Trump recently announced steep tariffs on pharmaceuticals and, in the latest update, a 100% levy on semiconductor imports. On the data front, Australia’s trade surplus jumped to AUD 5.37 billion in June 2025—its highest since March—driven by a 6.0% rise in exports to a 16-month high of AUD 44.32 billion. In corporate news, financial and healthcare stocks declined, while ASX Ltd tumbled 8.6% after flagging elevated costs tied to a regulatory probe. Focus now shifts to next week’s earnings, with major banks like CBA, Westpac, and ANZ set to report.